Boehncke WH,Schön MP .2015 .Disease burden and epidemiology. Lancet, 386 : 983-94.
Rendon A,Schäkel K. .2019 .Psoriasis pathogenesis and treatment. Int J Mol Sci, 10(6) : 1475.
Lim DS,Bewley A,Oon HH .2018 .Psychological Profile of patients with psoriasis. Ann Acad Med Singap, 47(12) : 516-22.
Christophers E.,Psoriasis E. .2001 .− epidemiology and clinical spectrum. Clin Exp Dermatol, 26(4) : 314-20.
Pezzolo E,Cazzaniga S,Colombo P,Chatenoud L,Naldi L .2019 .Psoriasis Incidence and Lifetime Prevalence: Suggestion for a Higher Mortality Rate in Older Age-classes among Psoriatic Patients Compared to the General Population in Italy. Acta dermato-venereologica, 10(3) : 00015555-3130.
Kimball AB,Wu EQ,Guérin A,Andrew PY,Tsaneva M,Gupta SR .2012 .Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol, 67(4) : 651-7.
Di Lernia V,Goldust M. .2018 .An overview of the efficacy and safety of systemic treatments for psoriasis in the elderly. Expert Opin Biol Ther, 10(8) : 897-903.
Fernandez-Torres RM,Paradela S,Fonseca E. .2012 .Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients. J Nutr Health Aging, 16(6) : 586-91.
Augustin M,Glaeske G,Radtke MA,Christophers E,Reich K,Schäfer I .2012 .Epidemiology and comorbidity of psoriasis in children. Br J Dermatol, 162(3) : 633-6.
Becker L,Tom WL,Eshagh K,Benjamin LT,Paller AS .2014 .Excess adiposity preceding pediatric psoriasis. JAMA Dermatol, 150(5) : 573-4.
Paller AS,Mercy K,Kwasny MJ,Choon SE,Cordoro KM,Girolomoni G .2013 .Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. JAMA Dermatol, 149(2) : 166-76.
Icen M,Crowson CS,McEvoy MT,Dann FJ,Gabriel SE,Kremers HM .2009 .Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol, 60(3) : 394-401.
Tollefson MM,Crowson CS,McEvoy MT,Kremers HM .2010 .Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol, 62(6) : 979-87.
Capon F. .2017 .The genetic basis of psoriasis. Int J Mol Sci, 18(12) : 2526.
Gladman DD,Anhorn KA,Schachter RK,Mervart H. HLA .1986 .antigens in psoriatic arthritis. J Rheumatol, 13(3) : 586-92.
Hugh JM .2018 .. Weinberg JM. Update on the pathophysiology of psoriasis. Cutis, 102(5S) : 6-12.
Søyland E,Heier I,Rodríguez‐Gallego C,Mollnes TE,Johansen FE,Holven KB .2010 .Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol, 10149(2) : 2133-55.
Kim WB,Jerome D,Yeung J .2017 .Diagnosis and management of psoriasis. Can Fam Physician, 63(4) : 278-85.
Zampetti A,Tiberi S .2015 .. Clin Med, 15(3) : 311.
Dupire G,Droitcourt C,Hughes C .2019 .Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev, 10 : .
Hoegler KM,John AM,Handler MZ,Schwartz RA .2018 .Generalized pustular psoriasis: a review and update on treatment. Journal of the European Acad Dermatol Venereol, 32(10) : 1645-51.
Engin B,Aşkın Ö,Tüzün Y .2017 .. Clin Dermatol, 35(1) : 19-27.
Arellano J,Yagnam M,Vidal M,Corredoira Y. .2017 .Eritrodermia psoriática en un hombre joven: sospechar infección por VIH. Rev Chilena Infectol, 34(6) : 603-6.
Valenzuela F,Fernández J,Sánchez M,Zamudio A .2018 .Erythrodermic psoriasis and human immunodeficiency virus: association and therapeutic challenges. An Bras Dermatol, 93 : 438-40.
Pasch MC .2016 .Nail psoriasis: a review of treatment options. Drugs, 76(6) : 675-705.
Alinaghi F,Calov M,Kristensen LE,Gladman DD,Coates LC,Jullien D .2019 .Prevalence of psoriatic arthritis in patients with psoriasis: a systematic review and meta-analysis of observational and clinical studies. J Am Acad Dermatol, 80(1) : 251-65.
Cruz NF,Brandão LS,Cruz SF,Cruz SA,Pires CA,Carneiro FR .2018 .Ocular manifestations of psoriasis. Arq Bras Oftalmol, 81(3) : 219-25.
Mrowietz U,Kragballe K,Reich K,Spuls P,Griffiths CE,Nast A .2011 .Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res, 303(1) : 1-0.
MacDonald A,Burden AD .2007 .Psoriasis: advances in pathophysiology and management. Postgrad Med, 83(985) : 690-7.
Kim HJ,Lebwohl MG .2019 .Biologics and psoriasis: the beat goes on. Dermatol Clin, 37(1) : 29-36.
Egeberg A,Ottosen MB,Gniadecki R,Broesby‐Olsen S,Dam TN,Bryld LE .2018 .Safety, efficacy and drug survival of biologics and biosimilars for moderate‐to‐severe plaque psoriasis. Br J Dermatol, 178(2) : 509-19.
Wang TS,Tsai TF .2019 .Biologics switch in psoriasis. Immunotherapy, 11(6) : 531-41.
Loft ND,Vaengebjerg S,Halling AS,Skov L,Egeberg A .2020 .Adverse events with IL‐17 and IL‐23 inhibitors for psoriasis and psoriatic arthritis: a systematic review and meta‐analysis of phase III studies. J Eur Acad Dermatol Venereol, 34(6) : 1151-60.
Kamata M,Tada Y .2020 .Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review. Int J Mol Sci, 10(5) : 1690.
Kazandjieva J,Grozdev I,Darlenski R,Tsankov N. .2008 .Climatotherapy of psoriasis. Clin Dermatol, 05(5) : 477-85.